IRS2靶向药基因BMS-754807

基因名称:IRS2  (insulin receptor substrate 2)

别名: IRS-2
基因ID:8660
Chromosome(GRCh37) :13 Start: 110406184 End: 110438915 Strand: -1
信号通路: 细胞增殖 
能量代谢
靶向药: BMS-754807
化疗药:

简介:该基因编码胰岛素受体底物2,这是一种胞质信号分子,通过充当不同受体酪氨酸激酶和下游效应器之间的分子接头来调节胰岛素、胰岛素样生长因子1和其他细胞因子的作用。这种基因的产物在受体刺激时被胰岛素受体酪氨酸激酶磷酸化,在IL4治疗后被白细胞介素4受体相关激酶磷酸化。This gene encodes the insulin receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of insulin, insulin-like growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors. The product of this gene is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment.
IRS2突变与药物:
AMPLIFICATION
药物:
BMS-754807 
疾病:
结直肠癌

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务